PRTCYPureTech Health plc
Next earnings Aug 26, 2026
$16.76
▲ +1.39%$16.76▼ -6.11%
over 1Y
L $15.75H $18.61
Today
+1.4%
1W
+3.9%
1M
-3.2%
3M
-6.1%
YTD
-6.1%
1Y
-6.1%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy
Mixed signals in the latest filings.
This call stands until the filings change it — the engine re-rates on new 10-K/10-Q/8-K facts, never on price moves. Hit Watch above to follow PRTCY (Pro alerts fire the moment a rating flips), or catch every change in Saturday’s Flip Side. How to read a call
PureTech Health plc shows limited reported revenue.
On these fundamentals, PRTCY screens as SELL on the SEC figures.
Is PRTCY a buy? The one-page verdict, explained →
The options angle
model · matches our verdictBear put spread~65d expiry
- Long put 17 @ ~1.10 est
- Short put 15 @ ~0.32 est
debit $78max +$122max −$78BE 16.22
SELL verdict, defined risk: profits into weakness down to the short strike; max loss is the net debit.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
No income data filed.
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$415M
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield—
FCF yield—
Quality & risk
ROIC (est.)—
Free cash flow—
Total debt—
Net cash—
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+0.9%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Recent filings
all on EDGAR ↗F-6 POSFiling2026-05-22open ↗424B3Filing2026-05-21open ↗15F-12BFiling2026-05-21open ↗25Filing2026-05-11open ↗SCHEDULE 13G/AFiling2026-05-11open ↗4Period ending 2026-05-042026-05-06open ↗6-KPeriod ending 2026-05-012026-05-01open ↗3Period ending 2026-04-302026-04-30open ↗SCHEDULE 13GFiling2026-04-29open ↗20-FPeriod ending 2025-12-312026-04-29open ↗6-KPeriod ending 2026-04-292026-04-29open ↗6-KPeriod ending 2026-04-292026-04-29open ↗
Frequently asked
- Is PureTech Health plc (PRTCY) a buy?
- PRTCY currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Mixed signals in the latest filings.
New filings change verdicts
The daily Brief delivers our freshest calls, rating flips and the filings behind them — every morning, free.
Sources: SEC EDGAR (CIK 0001782999, latest F-6 POS filed 2026-05-22) · EODHD · as of 7/15/2026, 8:09:58 PM.
About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice
Rule-based analysis, generated automatically from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 15, 2026, 4:09 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.